The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this has been the advancement of technologies that improve the time and efficiency of ...

The discovery of novel immunotherapies that specifically target and enhance the T-cell response against cancer, for example CAR-T cells, bispecific antibodies and checkpoint inhibitors, is a rapidly ...

Much of what biologists know about the human immune system has been — quite literally — illuminated by flow cytometry. For more than 70 years, this technology has evolved to become one of immunology’s ...

The following article is an opinion piece written by Rosa Sottile, PhD. The views and opinions expressed in this article are those of the author and do not necessarily reflect the official position of ...